Skip navigation

CBI’s Pharmaceutical Compliance Congress

April 26-28, 2017
  • Washington, DC

Backed by 13 years of high-quality content, CBI’s PCC is the industry’s must-attend event for compliance excellence, attracting more than 500 industry leaders annually. Join us in April, when the brightest minds and stakeholders of the highest caliber in life sciences compliance unite with an unmatched speaking faculty, meaningful networking and strategic content.

Compliance Champions of the Highest Caliber Driving the Dialogue:

William Weinreb
Acting U.S. Attorney
U.S. Attorney’s Office
for the District of Massachusetts

Cory LaBarge
Chief Compliance Officer,
Latin America
Grünenthal Group

Beth Levine
Senior VP, Associate
General Counsel, CCO
Regeneron Pharmaceuticals

Jill Fallows-Macaluso
Vice President,
Chief Compliance Officer
Novo Nordisk

Jennifer McGee
Chief Compliance Officer
Otsuka Pharmaceuticals

Edward Miller
Senior Vice President,
Chief Compliance Officer
Alexion Pharmaceuticals

Shannon Klinger
Chief Ethics & Compliance
Officer, Head of Litigation
Novartis

Howard Root
Co-Founder,
Chief Executive Officer
Vascular Solutions

View the complete faculty list of 80+ thought-leaders...

Powerful Programming and Compelling Content:

  • Women’s Executive Leadership Summit
  • 5 Interactive Workshops
  • Bio/Pharma and Medical Device Think Tank for Compliance Changemakers
  • Small to Mid-Sized Bio/Pharma Boot Camp
  • Industry-Only Compliance Café and Community Exchange
  • Past and Present Prosecutor Parley
  • Highly Acclaimed CCO Summit
  • 9 Tailored Content Streams on the Hottest Compliance Issues Transpiring Across the Globe
WHY ATTEND?

Previous Attendee Acclaim:

PCC provides something for all levels to walk away with.

HCC Officer, Johnson & Johnson

This conference provides the opportunity to learn best practices from the industry’s top experts.

Compliance Officer, Medicis Pharmaceutical Corporation

April 26-28, 2017 The Ritz-Carlton WASHINGTON, DC